{"id":"https://openalex.org/W4392686872","doi":"https://doi.org/10.1158/0008-5472.c.6506132.v1","title":"Data from Function-Blocking ERBB3 Antibody Inhibits the Adaptive Response to RAF Inhibitor","display_name":"Data from Function-Blocking ERBB3 Antibody Inhibits the Adaptive Response to RAF Inhibitor","publication_year":2023,"publication_date":"2023-03-30","ids":{"openalex":"https://openalex.org/W4392686872","doi":"https://doi.org/10.1158/0008-5472.c.6506132.v1"},"language":"en","primary_location":{"id":"doi:10.1158/0008-5472.c.6506132.v1","doi":"https://doi.org/10.1158/0008-5472.c.6506132.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/0008-5472.c.6506132.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"http://dx.doi.org/10.1158/0008-5472.c.6506132.v1","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5023867544","display_name":"Curtis H. Kugel","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Curtis H. Kugel","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050694888","display_name":"Edward J. Hartsough","orcid":"https://orcid.org/0000-0002-5109-3978","observed_orcids":["https://orcid.org/0000-0002-5109-3978"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Edward J. Hartsough","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048327749","display_name":"Michael A. Davies","orcid":"https://orcid.org/0000-0002-0977-0912","observed_orcids":["https://orcid.org/0000-0002-0977-0912"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael A. Davies","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038716576","display_name":"Yulius Y. Setiady","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yulius Y. Setiady","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5062746446","display_name":"Andrew E. Aplin","orcid":"https://orcid.org/0000-0002-2734-3244","observed_orcids":["https://orcid.org/0000-0002-2734-3244"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andrew E. Aplin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/her3","display_name":"HER3","score":0.9929999709129333},{"id":"https://openalex.org/keywords/raf-inhibitors","display_name":"RAF inhibitors","score":0.7570000290870667},{"id":"https://openalex.org/keywords/braf-mutant-melanoma","display_name":"BRAF-mutant melanoma","score":0.8270000219345093},{"id":"https://openalex.org/keywords/adaptive-resistance","display_name":"adaptive resistance","score":0.6679999828338623},{"id":"https://openalex.org/keywords/neuregulin-1","display_name":"neuregulin-1","score":0.890999972820282},{"id":"https://openalex.org/keywords/plx4720","display_name":"PLX4720","score":0.9789999723434448},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.878000020980835},{"id":"https://openalex.org/keywords/compensatory-signaling","display_name":"compensatory signaling","score":0.6759999990463257},{"id":"https://openalex.org/keywords/tumor-regrowth","display_name":"tumor regrowth","score":0.6909999847412109}],"concepts":[{"id":"https://openalex.org/C144745244","wikidata":"https://www.wikidata.org/wiki/Q4927286","display_name":"Blocking (statistics)","level":2,"score":0.7374049425125122},{"id":"https://openalex.org/C115456853","wikidata":"https://www.wikidata.org/wiki/Q17917132","display_name":"ERBB3","level":4,"score":0.6138407588005066},{"id":"https://openalex.org/C45121317","wikidata":"https://www.wikidata.org/wiki/Q4927287","display_name":"Blocking antibody","level":3,"score":0.5493209362030029},{"id":"https://openalex.org/C14036430","wikidata":"https://www.wikidata.org/wiki/Q3736076","display_name":"Function (biology)","level":2,"score":0.5044578313827515},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.40073859691619873},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.2664797306060791},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.25953835248947144},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.24472489953041077},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.2402344048023224},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.16888228058815002},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.16850578784942627},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.13377460837364197},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.08631855249404907},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.07592949271202087},{"id":"https://openalex.org/C31258907","wikidata":"https://www.wikidata.org/wiki/Q1301371","display_name":"Computer network","level":1,"score":0.05634111166000366}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/0008-5472.c.6506132.v1","doi":"https://doi.org/10.1158/0008-5472.c.6506132.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/0008-5472.c.6506132.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/0008-5472.c.6506132.v1","doi":"https://doi.org/10.1158/0008-5472.c.6506132.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/0008-5472.c.6506132.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9763000011444092}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1991831211","https://openalex.org/W1546041751","https://openalex.org/W2041907200","https://openalex.org/W4247701045","https://openalex.org/W2127258026","https://openalex.org/W2125883153","https://openalex.org/W2083435672","https://openalex.org/W7098501360","https://openalex.org/W4392687156","https://openalex.org/W2333651255"],"abstract_inverted_index":{"Abstract":[0],"ERBB3/HER3":[1],"expression":[2],"and":[3,65,82,88],"signaling":[4,23,67],"are":[5],"upregulated":[6,157],"in":[7,39,68,75,86,92,111,145,158],"mutant":[8,40,73,98],"BRAF":[9,41,74,99],"melanoma":[10,70,146],"as":[11,172],"an":[12],"adaptive,":[13],"prosurvival":[14],"response":[15,110,159],"to":[16,138,147,160],"FDA-approved":[17],"RAF":[18,28,37,120,143],"inhibitors.":[19],"Because":[20],"compensatory":[21],"ERBB3":[22,31,54,64,101,154],"counteracts":[24],"the":[25,34,53,104,133,140],"effects":[26],"of":[27,36,43,63,106,130,135,142],"inhibitors,":[29],"cotargeting":[30],"may":[32,166],"increase":[33],"efficacy":[35,141],"inhibitors":[38,144],"models":[42],"melanoma.":[44],"Here,":[45],"we":[46],"corroborate":[47],"this":[48],"concept":[49,131],"by":[50],"showing":[51],"that":[52],"function-blocking":[55],"monoclonal":[56],"antibody":[57],"huHER3-8":[58,78,116],"can":[59],"inhibit":[60],"neuregulin-1":[61],"activation":[62],"downstream":[66],"RAF-inhibited":[69],"cells.":[71],"Targeting":[72],"combination":[76],"with":[77,95,119],"decreased":[79,89],"cell":[80,84],"proliferation":[81],"increased":[83,114],"death":[85],"vitro,":[87],"tumor":[90,109,151],"burden":[91],"vivo,":[93],"compared":[94],"targeting":[96],"either":[97],"or":[100,149],"alone.":[102],"Furthermore,":[103],"likelihood":[105],"a":[107,127],"durable":[108],"vivo":[112],"was":[113,117],"when":[115],"combined":[118],"inhibitor":[121],"PLX4720.":[122],"Together,":[123],"these":[124,164],"results":[125],"offer":[126],"preclinical":[128],"proof":[129],"for":[132,169],"application":[134],"ERBB3-neutralizing":[136],"antibodies":[137],"enhance":[139],"delay":[148],"prevent":[150],"regrowth.":[152],"As":[153],"is":[155],"often":[156],"other":[161,170],"kinase-targeted":[162],"therapeutics,":[163],"findings":[165],"have":[167],"implications":[168],"cancers":[171],"well.":[173],"Cancer":[174],"Res;":[175],"74(15);":[176],"4122\u201332.":[177],"\u00a92014":[178],"AACR.":[179]},"counts_by_year":[],"updated_date":"2026-08-21T09:56:20.448147","created_date":"2024-03-13T00:00:00"}